You just read:

Armetheon Completes Acquisition of Budiodarone and Plans Development for the Treatment of Ventricular Tachycardia in Patients with Implantable Cardioverter Defibrillators

News provided by

Armetheon, Inc.

May 26, 2016, 08:00 ET